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ABSTRACT b-Mannans are hemicelluloses that are abundant in modern diets as
components in seed endosperms and common additives in processed food.
Currently, the collective understanding of b-mannan saccharification in the human
colon is limited to a few keystone species, which presumably liberate low-molecular-
weight mannooligosaccharide fragments that become directly available to the sur-
rounding microbial community. Here, we show that a dominant butyrate producer
in the human gut, Faecalibacterium prausnitzii, is able to acquire and degrade various
b-mannooligosaccharides (b-MOS), which are derived by the primary mannanolytic
activity of neighboring gut microbiota. Detailed biochemical analyses of selected
protein components from their two b-MOS utilization loci (F. prausnitzii b-MOS utili-
zation loci [FpMULs]) supported a concerted model whereby the imported b-MOS
are stepwise disassembled intracellularly by highly adapted enzymes. Coculturing
experiments of F. prausnitzii with the primary degraders Bacteroides ovatus and
Roseburia intestinalis on polymeric b-mannan resulted in syntrophic growth, thus
confirming the high efficiency of the FpMULs’ uptake system. Genomic comparison
with human F. prausnitzii strains and analyses of 2,441 public human metagenomes
revealed that FpMULs are highly conserved and distributed worldwide. Together, our
results provide a significant advance in the knowledge of b-mannan metabolism
and the degree to which its degradation is mediated by cross-feeding interactions
between prominent beneficial microbes in the human gut.
IMPORTANCE Commensal butyrate-producing bacteria belonging to the Firmicutes phy-
lum are abundant in the human gut and are crucial for maintaining health. Currently,
insight is lacking into how they target otherwise indigestible dietary fibers and into the
trophic interactions they establish with other glycan degraders in the competitive gut
environment. By combining cultivation, genomic, and detailed biochemical analyses, this
work reveals the mechanism enabling F. prausnitzii, as a model Ruminococcaceae within
Firmicutes, to cross-feed and access b-mannan-derived oligosaccharides released in the
gut ecosystem by the action of primary degraders. A comprehensive survey of human
gut metagenomes shows that FpMULs are ubiquitous in human populations globally,
highlighting the importance of microbial metabolism of b-mannans/b-MOS as a
common dietary component. Our findings provide a mechanistic understanding of the
b-MOS utilization capability by F. prausnitzii that may be exploited to select dietary
formulations specifically boosting this beneficial symbiont, and thus butyrate production,
in the gut.
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The human distal gut supports a densely populated microbial community thatextends the metabolic capabilities lacking in the host genome (1). In particular, re-
calcitrant glycans that are resistant to human digestive enzymes are broken down by
the colonic microbiota to monosaccharides and further fermented into host-absorb-
able short-chain fatty acids (SCFAs). Microbial-borne SCFAs serve critical functions both
as energy sources and regulators of inflammation, cell proliferation, and apoptosis (2).
Therefore, catabolism of complex dietary carbohydrates reaching the distal part of the
gastrointestinal tract has a central role in shaping the structure and metabolic output
of the human gut microbiota and, in turn, host health status (3).
Members of the Gram-positive Firmicutes and the Gram-negative Bacteroidetes
phyla constitute the majority of the bacteria found in this ecosystem (4), individual
species of which have evolved different strategies to harvest energy from the available
dietary glycans (5). Within the Bacteroidetes, Bacteroides spp. have been extensively
investigated with respect to carbohydrate degradation, and they are considered gener-
alists, displaying broad plasticity for glycan utilization (5). Bacteroides spp. are particu-
larly notable for dedicating large proportions of their genome to carbohydrate utiliza-
tion, organizing genes coding for functionally related carbohydrate active enzymes
(CAZymes) and transport and regulatory proteins into polysaccharide utilization loci
(PULs) (6). Despite variations in the polysaccharides they target, the key feature of a
PUL is the presence of one or more TonB-dependent receptor (SusC homolog) and a
contiguous substrate-binding lipoprotein (SusD homolog). Compared with Bacteroides,
Firmicutes encode a lower proportional number of CAZymes and are thought to be
nutritionally specialized for selected glycans (1, 5). Recently, species within the
Firmicutes phylum have been shown to organize cohorts of genes encoding glycan uti-
lization systems into loci and being primary degraders of common dietary carbohy-
drates (7–9). Firmicutes typically utilize glycan-specific ATP-binding cassette (ABC)
transporters, which mediate high-affinity capture of oligosaccharides via their extracel-
lular solute-binding proteins (SBPs) (5).
Faecalibacterium prausnitzii, a member of the Ruminococcaceae family within the
Firmicutes phylum, is one of the three most abundant species detected in the human
gut microbiota and one of the main sources of butyrate in the colon (10). A growing
body of evidence recognizes the crucial role played by F. prausnitzii populations in
maintaining local and systemic host health, as they are often found to be less abun-
dant in individuals affected by colorectal cancer (11) and certain forms of inflammatory
disorders, including alternating-type irritable bowel syndrome (IBS), inflammatory
bowel diseases, celiac disease, obesity and type 2 diabetes, appendicitis, and chronic
diarrhea (12, 13). In addition, studies in mouse models have demonstrated that both
cell and supernatant fractions of F. prausnitzii reduce the severity of acute, chronic, and
low-level chemically induced inflammations (14, 15). F. prausnitzii also contributes to
colonic epithelial homeostasis by stimulating the production of mucin O-glycans and
by maintaining appropriate proportions of different cell types of the secretory lineage
(16). Collectively, these aforementioned properties make F. prausnitzii a potential novel
health-promoting probiotic (17), and interventions aimed at increasing the representa-
tion of these butyrate-producing bacteria may be used to confer protection against
several intestinal disorders.
A common component of the human diet are b-mannans. These complex plant gly-
cans are found in high concentrations as naturally occurring dietary fibers in certain
nuts, beans, legume seeds, tomato seeds, coconut, and coffee beans (18). In addition,
mannan hydrocolloids, including guar gum and carob galactomannan (CGM) as well as
konjac glucomannan (KGM), are widely used in the food industry to improve the rheo-
logical properties of processed products (19). The constant exposure of the gut bacte-
rial community to dietary mannans is consistent with the finding that b-mannan
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metabolism is one of the core pathways in the human gut microbiota (20). Structurally,
b-mannans display source-related diversity with respect to the presence of b-1,4-
linked mannosyl and glycosyl residues, a-1,6-linked galactosyl groups and acetyl deco-
rations at positions O-2, O-3, and/or O-6 (18). PULs degrading homopolymeric mannan
and galactomannan have been described in the glycan generalists Bacteroides fragilis
and Bacteroides ovatus, respectively (21, 22). We recently reported the characterization
of a novel b-mannan utilization locus conferring Roseburia intestinalis, a model for the
clostridial cluster XIVa (Lachnospiraceae) Firmicutes, with the ability to ferment this fiber
through to butyrate via a selfish mechanism (7). b-Mannan degradation was proven to
be initiated by an endo-acting multimodular GH26 enzyme localized on the cell sur-
face; the resulting oligosaccharides are imported intracellularly through a highly spe-
cific ABC transporter, and completely depolymerized to their component monosaccha-
rides by an enzymatic cocktail containing carbohydrate esterases, b-glucosidases, and
phosphorylases (7).
Although F. prausnitzii has been described as an efficient degrader of host-derived
and plant glycans (23), the ability of this important butyrate-producing microbe to utilize
dietary b-mannans has received little attention. In a previous study, we reported that
wood-derived acetylated galactoglucomannan stimulates the proliferation of F. prausnit-
zii populations in a pH-controlled batch culture fermentation system inoculated with
healthy adult human feces (24). However, the molecular mechanism underlining b-man-
nan utilization by F. prausnitzii in the human gut has not been explored thus far.
In this study, we describe and biochemically characterize components of two loci
that mediate acquisition and catabolism of b-mannooligosaccharides (b-MOS) by
the human gut isolate F. prausnitzii SL3/3. Together, these data allowed us to outline
a pathway for dietary b-MOS deconstruction and saccharification to monosaccha-
rides through cross-feeding with Bacteroides and Roseburia species, which contrib-
utes to the ecology of b-mannan utilization in the gut ecosystem. Remarkably, we
show that the binding proteins that confer b-MOS capture in F. prausnitzii targeted
ligands with stronger affinity than that of Bacteroides species, thus providing F. praus-
nitzii with the ability to cross-feed on the b-MOS available in the environment with
high efficiency.
RESULTS
F. prausnitzii possess two loci for utilization of b-mannan breakdown products.
Based on the similarity with the components from the previously characterized b-man-
nan utilization system in R. intestinalis (7), genes encoding enzymatic activities required
to catabolize mannans were identified within two putative mannan utilization loci
(MULs) in F. prausnitzii SL3/3 (Fig. 1a). The large MUL from F. prausnitzii (FpMULL) con-
sists of 14 genes encoding nine enzymes, the components of an ABC transporter, a
predicted LacI-type transcriptional regulator (TR), and a hypothetical protein (Fig. 1a).
The enzymes encoded by FpMULL include an a-galactosidase belonging to the glyco-
side hydrolase (GH) family 36 (FpGH36), two carbohydrate esterases (CEs [FpCE2 and
FpCE17]), a GH113 (FpGH113), one epimerase (FpMep), a b-1,4-mannooligosaccharide
phosphorylase (FpGH130_2), a mannosylglucose phosphorylase (FpGH130_1), a phos-
phomutase (FpPmm) and a GH1 isomerase (FpGH1). In addition, genes encoding two
predicted GH3 b-glucosidases (FpGH3A and FpGH3B) were identified. These two genes
are located in a different locus in the genome, hereafter referred to as FpMULS, and are
likely to be involved in (galacto)glucomannan turnover. Based on known activities
within GH families, the b-1,4-mannan backbone is predicted to be hydrolyzed by
extracellular GH26, GH5, and/or GH134 enzymes (see www.cazy.org). However, no
gene coding for such an enzyme was identified in the genome of F. prausnitzii SL3/3.
In addition, endo-b-1,4-mannanase activity was originally reported for two GH113
enzymes (see www.cazy.org), although we demonstrated that a GH113 within the
mannan utilization locus of R. intestinalis is a reducing end mannose-releasing exo-oli-
gomannosidase. A gene encoding a GH113 was detected in the FpMULL (Fig. 1a).
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Based on the results of a genomic context analysis and in silico prediction of a signal
peptide, FpGH113 would function as an intracellular mannanase or mannosidase; thus,
its enzymatic function could not be assigned before an in-depth biochemical charac-
terization (see later results for FpGH113).
FIG 1 F. prausnitzii loci involved in b-mannooligosaccharide degradation and metagenomic analysis of the occurrence of the loci in 2,441 human
metagenomes. (a) Large and small b-mannooligosaccharide utilization loci (MULL and MULS, respectively) genomic structure in F. prausnitzii SL3/3 and
across other publicly available F. prausnitzii genomes. In F. prausnitzii SL3/3, locus tag numbers FPR_XXXXX are abbreviated with the last numbers after the
low line (_). FpMULS corresponds to the genes 09740 to 09750, while FpMULL includes the genes 17180 to 17320. Numbers between each gene indicate
the amino acid identity (%) of the encoded protein. Numbers below S. variabile CIM:MAG1127 genes indicate the amino acid identity (%) of the encoded
proteins shared with the same protein in F. prausnitzii SL3/3. (b) Prevalence of FpMULL as well as both FpMULL and FpMULS (two MULs) in human
metagenomes. Each line denotes the presence (blue or yellow) or absence (black) of the FpMULL/MULs related in a single human gut metagenomic
sample. The numbers below the bottom row represent the frequency of FpMULs that each cohort possesses. The frequency of FpMULL/MULs incidence
across all 2,441 individuals is shown on the right. CRC, colorectal cancer; RA, rheumatoid arthritis; CD, Crohn's disease; UC, ulcerative colitis.
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Genomic comparisons showed that homologous systems to the FpMULL and
FpMULS occur in other sequenced Faecalibacterium members with high percentages of
identity (Fig. 1a). Comparison of the gene organization and protein sequence also
revealed various levels of rearrangements and moderate protein homology with the
two b-mannan utilization loci from R. intestinalis. Examination of the regions flanking
the FpMULL of F. prausnitzii SL3/3 showed the presence of genes encoding plasmid
mobilization-related proteins, including a cell invasion protein, a relaxase MobA/VirD2,
and a DNA ligase (Fig. 1a). Interestingly, R. intestinalis L1-82 genome harbors a similar
region, including genes coding for the same plasmid-related components, suggesting
that the origin of FpMULL could be the result of horizontal transfer through bacterial
conjugation within colonic microbes. Further comparisons revealed that the genes
located upstream and downstream of the FpMULL of F. prausnitzii M21/2 and six other
sequenced F. prausnitzii strains code for an incomplete prophage, including one or
two relaxases and an integrase (Fig. 1a). On the basis of these results, we hypothesize
that phage-related horizontal gene transfer was an alternative mechanism for the ac-
quisition of this cluster at the same point in the evolutionary history of these strains.
Orthologues of both MULL and MULS, with some rearrangements, were identified in
Subdoligranulum variabile CIM:MAG 1127, suggesting that mannan utilization could be
a metabolic feature shared with other Ruminococcaceaemembers.
To further understand the distribution of the two MULs within human-associated F.
prausnitzii strains, we surveyed the publicly available metagenome data from a total of
2,441 individuals from regions with distinct geography (North America, Europe, China,
and Japan) and dietary patterns (Fig. 1b). Overall, 26.35% of the subjects harbor the
two FpMULs identified in this study, while 37.70% carry the FpMULL, irrespective of the
nationality or health state. When examined for frequency within single data sets, differ-
ent cohorts and nationalities exhibited differing trends. The two FpMULs were most
common in the European (up to 40.75% of the subjects), Chinese (up to 48.27%), and
Japanese (20.31%) metagenomes, whereas their prevalence was lower in North
American (10.68%) metagenomes. Among the two hunter-gatherer populations, the
Yanomami and Hadza, we detected the presence of only FpMULL in one Yanomami
and two Hadza individuals, indicating that these microbiomes may be able to degrade
galactomannan derived from tubers that are part of their diet (25).
F. prausnitzii grows efficiently on b-mannooligosaccharides. Growth studies
showed that F. prausnitzii SL3/3 failed to grow on KGM and CGM (Fig. 2a), likely reflect-
ing the absence of a surface b-1,4-endomannanase required to generate suitable
FIG 2 Growth profile and carbohydrate consumption of F. prausnitzii SL3/3. (a) Cells were grown on M2 medium supplemented with 0.2% (wt/vol)
polysaccharide (CGM, carob galactomannan; KGM, konjac glucomannan), oligosaccharides (GH26-CGM, RiGH26-pretreated carob galactomannan; GH26-
KGM, RiGH26-pretreated konjac glucomannan), cellobiose (Glc2), and glucose (Glc) as the sole carbon source. Data are averages 6 standard deviations
(error bars) of three biological replicates. (b) Analysis of the growth medium used in the experiment described in panel a by HPAEC-PAD. Traces show
mannose, mannooligosaccharides, and polysaccharides detected in the supernatant before (T0h) and after fermentation (T24h) with F. prausnitzii. Samples
were chromatographed with the following external standards: M1, mannose; M2, mannobiose; M3, mannotriose; M5, mannopentaose; M6, mannohexaose.
The data displayed are examples from three biological replicates.
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b-MOS for import into the cell. This hypothesis was confirmed by growing F. prausnitzii
on both substrates predigested with a GH26 b-1,4-endomannanase from R. intestinalis
(Fig. 2a). To assay for oligosaccharide generation and/or uptake, we used high-per-
formance anion-exchange chromatography with pulsed amperometric detection
(HPAEC-PAD) and determined the concentration of b-MOS in the initial and spent su-
pernatant from F. prausnitzii cultures (Fig. 2b). Only polymeric b-mannan was observed
in the spent supernatant after growth of the bacterium on KGM and CGM, demonstrat-
ing that F. prausnitzii does not display surface b-1,4-endomannanase activity. In con-
trast, F. prausnitzii was able to take up and utilize CGM- and KGM-derived b-MOS while
mannose and mannobiose (M2) are seemingly untouched.
Taken together, these data support the concept that the two MULs are being
expressed and the resulting proteins orchestrate the degradation of different b-MOS. To
determine the biochemical basis for b-MOS import and deornamentation, the specificity
of the b-MOS-binding protein, FpGH36, FpGH113, and the two CEs was determined. A
model for catabolism of CGM- and KGM-derived b-MOS is presented in Fig. 3.
FpMOBP is a binding protein specific for b-MOS. In a previous study, we have
shown that the binding protein RiMnBP of R. intestinalis is part of an ABC transporter that
confers uptake of b-MOS with a degree of polymerization between 3 and 6 (7). The
FpMUL harbors the components of an ABC transporter similar to that of R. intestinalis,
whereby FpMOBP is a 48-kDa protein sharing 48% identity with RiMnBP. In order to con-
firm the expected role of FpMOBP in capturing b-MOS, we assessed the binding of the
recombinantly produced protein to mannohexaose using isothermal titration calorimetry
(ITC). FpMOBP bound to mannohexaose with a Kd (dissociation constant) of 1896 1.4mM
(DG = 25.086 0.01 kcal/mol; DH = 219.86 0.28 kcal/mol; TDS = 14.76 0.14 kcal/mol; n =
0.8; corresponding thermograms are shown in Fig. S1a in the supplemental material).
FpMOBP did not show any appreciable binding to cellohexaose (Fig. S1b), demonstrating
the specificity of FpMOBP toward mannopyranosyl-linked ligands. Together, these data
demonstrate that FpMOBP is part of an ABC transporter specific for b-MOS.
FpGH113 is a reducing end mannose-releasing exo-oligomannosidase. FpGH113
is a 35-kDa protein sharing 53% identity with RiGH113 from the previously characterized
b-mannan utilization system in R. intestinalis (7) (Fig. 1). The closest structurally charac-
terized homolog of FpGH113 is the b-1,4-mannanase AxMan113A from Amphibacillus
xylanus (26) with 48% identity between the two amino acid sequences. No signal pep-
tide was identified by SignalP 4.0, suggesting that FpGH113 is likely located intracellu-
larly. The FpGH113 enzyme released mannose and oligosaccharides from 63,64-a-D-galac-
tosyl-mannopentaose (Gal2Man5) (Fig. S2a and b) and mannopentaose (Man5) (Fig. 4a),
with mannose increasing over time (Fig. S2c), consistent with exo-activity. When the
reducing end of Man5 was reduced with sodium borodeuteride (NaBD4) (Fig. 4a), no
FpGH113 activity could be detected, demonstrating that this enzyme is a reducing end
mannose-releasing exo-oligomannosidase. Considering the predicted intracellular loca-
tion of FpGH113, we tested its activity against RiGH26-prehydrolyzed CGM. Consistent
with this view, release of mannose was detected after overnight incubation of the
enzyme with RiGH26-generated galacto-b-MOS (Fig. 4b), while FpGH113 was not able to
hydrolyze intact CGM (Fig. S2d).
Removal of a-galactosyl and acetyl substitutions from b-MOS. FpGH36 is a pre-
dicted intracellularly localized 79-kDa enzyme with two GH36 domains, located at the
N and C termini of the protein, as well as an internal melibiase domain. The F. prausnit-
zii GH36 domains were all similar to those found in well-characterized a-galactosi-
dases, with AgaB from the thermophilic bacterium Geobacillus stearothermophilus
being the closest structurally characterized homolog (44% identity) (27). FpGH36
showed 42% identity to RiGH36 from R. intestinalis (Fig. 1). FpGH36 hydrolyzed a-1,6-
galactose side chains from CGM-derived b-MOS (Fig. 4c) and Gal2Man5 (Fig. S1a and
b), exhibiting minor activity against polymeric galactomannan (Fig. 4c). This is consist-
ent with the sequential activity of FpGH36 on internalized galacto-b-MOS in vivo.
We have previously shown that in R. intestinalis the complete removal of acetyl sub-
stitutions on the b-MOS backbone is achieved through the complementary action of
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two esterases, where RiCE2 attacks acetyl groups on either the 3-O, 4-O, or 6-O posi-
tion, while RiCE17 attacks acetyl groups on the 2-O position (28). To explore whether
F. prausnitzii employs a similar mechanism, KGM was prehydrolyzed with RiGH26 to
generate glucomanno-oligosaccharides (GMOS) that were subsequently incubated
FIG 3 Schematic model of the b-MOS degradation pathway in F. prausnitzii. Gene products are colored as in Fig. 1. b-MOS liberated by b-mannan
keystone species are bound on the surfaces of the F. prausnitzii cells by the MOBP-binding protein. The b-MOS transit intracellularly through the
associated ABC transporter. Once intracellular, the a-galactosidase GH36 and the reducing end mannose-releasing exo-oligomannosidase GH113
process the galactomannooligosaccharides into galactose, mannose, and mannotriose. The glucomannooligosaccharides are processed by the
acetylesterases CE2 and CE17, two b-glucosidases (GH3), and the reducing end mannose-releasing exo-oligomannosidase GH113 into acetate,
mannose, glucose, and mannotriose. The mannotriose is hydrolyzed by the b-1,4-mannooligosaccharide phosphorylase GH130_2 into mannose-1-
phosphate and mannobiose, which is then epimerized to mannosyl-glucose by an epimerase. A b-1,4-mannosylglucose phosphorylase GH130_1
phosphorolyses mannosyl-glucose into mannose-1-phosphate and glucose. The mannose-1-phosphate is converted into mannose-6-phosphate by a
mannose phosphate mutase (Pmm) and further isomerized into fructose-6-phosphate by a GH1. This product, together with the other liberated
monosaccharides and acetate, enters glycolysis that generates pyruvate, some of which is converted into butyrate. Proteins characterized in this
study are indicated by asterisks.
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FIG 4 HPAEC-PAD and MALDI-ToF analysis of the activity of enzymes removing acetyl and galactosyl side chains and further hydrolyzing the imported
b-MOS. (a) Mannose and b-MOS generated when FpGH113 was incubated with mannopentaose (M5). FpGH113 was unable to hydrolyze M5 that had been
pretreated with sodium borodeuteride (NaBD4) to convert the reducing end monosaccharide unit into its alditol. Control reaction with the previously
characterized reducing end mannose-releasing exo-oligomannosidase RiGH113 and endo-mannanase RiGH26 are shown. (b) HPAEC-PAD traces of the
product generated before and after hydrolysis of RiGH26-pretreated carob galactomannan (GH26-CGM) and RiGH26-pretreated konjac glucomannan (GH26-
KGM) with FpGH113. (c) HPAEC-PAD trace showing the oligosaccharide products of CGM digestion with RiGH26 and subsequently incubated with FpGH36
a-galactosidase. (d) MALDI-ToF spectra showing products (as sodium adducts) generated after incubation of predigested KGM (RiGH26-KGM) with either
FpCE17 or FpCE2 or both enzymes in combination. Peaks are labeled by degree of polymerization (DP) and number of acetyl (Ac) groups. Intensity is
shown in arbitrary units (AU). (e) Mass spectra of mannohexaose containing acetylations at different positions after treatment with either FpCE17 or FpCE2.
These substrates were generated in-house using the R. intestinalis esterases RiCE2 and RiCE17. The annotated m/z values indicate sodium adducts. (f) pH
optima of FpCE17 or FpCE2. pH optima were determined on pNP acetate in 50mM sodium phosphate buffers with different pHs at room temperature.
(Continued on next page)
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with FpCE2 (32% amino acid sequence identity with RiCE2) and FpCE17 (46% amino
acid sequence identity with RiCE17). Matrix-assisted laser desorption ionization2time
of flight mass spectrometry (MALDI-ToF MS) analysis of products released from GMOS
revealed that the two enzymes mediated the complete removal of acetylations when
added together, while a partial deacetylation was observed when the substrate was
treated with each of the enzymes separately (Fig. 4d). To explore the extent to which
this strategy for complete substrate deacetylation is conserved in Firmicutes, we
exploited the transacetylation specificity of R. intestinalis esterases (28) to generate ace-
tylated mannohexaoses (AcM6) and tested the activity of FpCE2 and FpCE17 on these
substrates. FpCE2 was able to deacetylate only the RiCE2-generated AcM6, thus demon-
strating that this enzyme removes 3-O-, 4-O-, and 6-O-acetylations (Fig. 4e). FpCE17
was effective on RiCE17-generated AcM6 and displayed no activity on RiCE2-generated
AcM6, thus showing that FpCE17 exclusively removes the axially oriented 2-O-acetyla-
tions (Fig. 4e). Taken together, these results prove that the F. prausnitzii esterases have
the same acetylation site specificity as their corresponding enzymes in R. intestinalis.
To further characterize the two F. prausnitzii esterases, we evaluated their activity
both on a commercial substrate, i.e., para-nitrophenyl (pNP) acetate, and on a natural
substrate, i.e., RiGH26 hydrolyzed acetylated galactoglucomannan (AcGGM). When
tested on pNP acetate, both FpCE2 and FpCE17 were most active at pH 6.75 (Fig. 4f).
Deacetylation rate measurements on RiGH26-prehydrolyzed AcGGM at pH 6.75 and
35°C, conditions that prevent acetyl migration, at equal enzyme loadings (50 nM) indi-
cated that FpCE2 releases acetate approximately four times faster than FpCE17
(Table 1). When combined, using 25 nM of each esterase, the deacetylation rate, kcat,
and specific activity were approximately two-fold higher than the values from treat-
ments with FpCE17 and two-fold lower than the values from treatments with the
FpCE2 when used on its own, respectively (Table 1).The reduced resulting rate of
deacetylation suggests that the esterases are not acting synergistically but may rather
be competing for the substrate, a behavior previously reported in cocktails of multiple
enzymes for lignocellulose hydrolysis (29).
Melting curves for both enzymes in buffers at pH 5.0 to 8.0 were obtained using a
protein thermal shift assay (Fig. 4g and h). Both FpCE2 and FpCE17 displayed an
irreversible thermal unfolding transition, which is consistent with their multidomain
structure (28, 30). FpCE17 was stable up to 73°C, with the highest observed melting
temperature at pH 6.0; its lowest observed melting temperature was 58°C at pH 5. For
FpCE2, the unfolding took place at higher temperature, with a melting point of 62°C at
pH 6.0 and a highest melting point of 73°C at pH 7.0 and 8.0 (Fig. 4g and h); its lowest
observed melting temperature was 56°C at pH 5.0.
Studies of substrate specificities have shown that acetyl esterases are able to effi-
ciently catalyze the transfer of an acetyl group from a donor, such as vinyl acetate, to
precise positions of an oligosaccharide with the generation of highly specific esterified
FIG 4 Legend (Continued)
Acetate release was measured after a 10-min incubation. (g) Thermal shift assay melting curve for FpCE17. (h) Thermal shift assay melting curve for FpCE2.
Both in panels g and h, plots show derivative fluorescence data (-F) as a function of temperature (°C). (i) MALDI-ToF MS analysis of reactions for
identification of preferred oligosaccharides for FpCE2 and FpCE17. The esterases were tested on a mix with mannotriose (m/z 527; M3), cellotetraose (m/z
689; G4), and xylopentaose (m/z 701; X5) and with vinyl acetate, vinyl propionate, and vinyl butyrate as ester donors. In all panels, data are representative
of independent triplicates. Abbreviations: M1, mannose, M2, mannobiose; M3, mannotriose; M4, mannotetraose; M5, mannopentaose; M6, mannohexaose,
Gal1, galactose; Gal1M3, galactosylmannotriose; Gal1M4, galactosylmannotetraose; Gal2M4, digalactosylmannotetraose; Gal2M5, digalactosylmannopentaose.
TABLE 1 Deacetylation rate, specific activity, and turnover rates of FpCE2 and FpCE17 on
AcGGM from Norway sprucea
Parameter FpCE17 FpCE2 FpCE17+FpCE2
Deacetylation rate (nmol/s) 4,166 16,550 7,588
kcat (s
21) 83 331 152
sp act (nmol acetate/s/mg enzyme) 2 8
aValues are calculated based on the acetate released in the initial 15 min of reaction.
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oligosaccharides (28). Consistent with that notion, we found that both F. prausnitzii
esterases were able to transacetylate mannotriose (M3) and mannotetraose (data not
shown). To further test the preferred substrate for the esterases, we incubated either
FpCE17 or FpCE2 with a mix of M3, cellotetraose (G4), and xylopentaose (X5) and used
vinyl acetate as an acetyl donor. MALDI-ToF MS analysis of products generated by
these reactions showed that the esterases transferred the acetyl group only to M3
(Fig. 4i), thus confirming the manno-oligosaccharide specificity of FpCE17 and FpCE2.
Cocultivation of F. prausnitzii with primary b-mannan degraders. The data pre-
sented above suggest that F. prausnitzii has a sufficiently complex enzymatic toolbox to ben-
efit from the uptake of b-MOS liberated in the surrounding environment by other gut
microbes. To test this hypothesis and evaluate the competitiveness of this strain in the utili-
zation of b-MOS, we cocultured F. prausnitzii with two keystone commensal organisms for
b-mannan utilization, namely, the Gram-negative Bacteroidetes B. ovatus strain V975 and the
Gram-positive Firmicutes R. intestinalis strain L1-82. F. prausnitzii grew in the presence but
showed poor growth in the absence of B. ovatus on intact KGM (Fig. 5a). The optical den-
sities obtained when F. prausnitzii was grown in monoculture in the no-carbon source con-
trol (Fig. 5b) were similar to those obtained in KGM, suggesting that the microbe is not able
to utilize this glycan on its own. Notably, the maximum optical density at 650 nm (OD650) of
the coculture (OD650 = 0.55) appeared higher in the b-mannan polymer than those
observed for B. ovatus in single culture (OD650 = 0.49), indicating that syntrophic growth
exists between these two populations under these conditions (Fig. 5a). The two strains
showed comparable growth on glucose (Fig. 5c). F. prausnitzii is a butyrate producer, while
carbohydrate fermentation by B. ovatus results in the production of propionate (5).
Therefore, comparing differences in butyrate levels between the single F. prausnitzii culture
and coculture may provide evidence as to whether cross-feeding of b-mannan breakdown
products by F. prausnitzii occurred. Butyrate concentrations were significantly increased
(P = 0.001) in the coculture compared to the monococulture in KGM (Fig. 5d), the coculture
in minimal medium with no carbon source (Fig. 5e) or glucose (Fig. 5f), which suggests that
F. prausnitzii can effectively compete for b-MOS generated by the cell-surface-exposed
endo-mannanase BoMan26B from B. ovatus (31). This effect required the presence of living
B. ovatus cells, as no evidence of an increase of butyrate levels was detected when F. praus-
nitzii was cogrown with a heat-treated B. ovatus culture (Fig. S3). Population estimates using
quantitative PCR (qPCR) showed that, while no growth was observed when F. prausnitzii was
cultivated singly on KGM, it grew well in the coculture supplemented with KGM (Fig. 5g),
thus indicating cross-feeding activity by F. prausnitzii. Both F. prausnitzii and B. ovatus dis-
played similar growth on glucose (Fig. 5h), suggesting that the bacteria shared the available
carbon source and maintained coexistence. When F. prausnitziiwas cocultured with R. intesti-
nalis in KGM, in the absence of a carbon source or in glucose, the growth curves appeared
very similar to when R. intestinalis was cultured on its own (Fig. 5i to k). As both bacteria pro-
duce butyrate, we compared the value observed in the coculture to the sum of butyrate
concentration in both single cultures. No significant increase (P . 0.05) of butyrate concen-
trations was observed in the coculture compared to the single cultures in KGM (Fig. 5l), mini-
mal medium (Fig. 5m), or minimal medium plus glucose (Fig. 5n). Intriguingly, while no
growth was observed in monococulture in KGM, F. prausnitzii displayed growth in coculture
with R. intestinalis (Fig. 5o), thus demonstrating cross-feeding behaviors. When growing in
coculture on glucose, R. intestinalis dominated the culture and outcompeted F. prausnitzii
(Fig. 5p). Notably, cocultivation of F. prausnitzii with either B. ovatus (Fig. 5b) or R. intestinalis
(Fig. 5j) without any carbon source resulted in no increase in the overall levels of butyrate in
the cocultures (Fig. 5e and m). These data indicate the specific effect of KGM degradation
products to support F. prausnitzii growth and exclude the possibility that this microbe is
cross-feeding on bacterial-derived components (such as capsular polysaccharides).
DISCUSSION
Biochemical work presented herein demonstrates that two MULs support the ability
of F. prausnitzii to utilize b-MOS. b-MOS from diet are highly variable with respect to
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sugar composition and linkages, and the F. prausnitzii enzymatic apparatus is adapted to
deal with this diversity. Our findings show that b-MOS are bound by FpMOBP at the cell
surface and subsequently imported intracellularly; here, they are further saccharified by
FpGH113 and degalactosylated and deacetylated by the combined action of FpGH36,
FpCE2, and FpCE17 (Fig. 3). By analogy with the model described for R. intestinalis (7),
putative b-glucosidases of GH3 may confer the removal of terminal glucose residues in
gluco-b-MOS prior to depolymerization of the remaining linear b-MOS by the activity of
a putative mannooligosaccharide phosphorylase (FpGH130_2) into mannobiose.
Mannobiose is subsequently epimerized into mannosyl-glucose by a putative epimerase,
FpMep, and phosphorolysed by FpGH130_1 into glucose and mannose-1-phosphate,
similar to the pathway described for Ruminococcus albus (32). As shown for R. intestinalis
FIG 5 Cocultivation experiments of F. prausnitzii with keystone b-mannan degraders. (a to c) Growth kinetics of mono- and cocultures of F. prausnitzii (Fp)
and B. ovatus (Bo) in M2 medium containing 0.2% konjac glucomannan (KGM) (a), no carbon source (no carbon) (b), or 0.2% glucose (c). (d to f)
Fermentation products for mono- and cocultures of F. prausnitzii (Fp) and B. ovatus (Bo) (d), KGM with no carbon source (e) or glucose (f). 16S rRNA gene-
targeted qPCR data signifying changes in relative abundance for F. prausnitzii (Fp) and B. ovatus (Bo) in monococulture and coculture in KGM (g) or glucose
(h). (i to k) Growth of single and cocultures of F. prausnitzii (Fp) and R. intestinalis (Ri) in M2 medium supplemented with 0.2% konjac glucomannan (KGM)
(i), no carbon source (j), or glucose (k). (l to n) Concentration of different metabolites in the spent media of single and cocultures of F. prausnitzii (Fp) and
R. intestinalis (Ri) in M2 medium with 0.2% konjac glucomannan (KGM) (l), no carbon source (m), or glucose (n). (o and p) 16S rRNA gene-targeted qPCR
data signifying changes in relative abundance, for F. prausnitzii (Fp) and R. intestinalis (Ri) in monococulture and coculture in KGM (o) or glucose (p). In
panels g, h, o, and p, the number of 16S rRNA gene copies per milliliter of culture, obtained using qPCR, at the start (T0) and end (T48) of the
experimental run were expressed as T48/T0 to obtain fold changes which were then log2 transformed. In all panels, the data are means with standard
deviations of a minimum of three replicates. For calculation of SCFA concentrations, the values measured in uninoculated M2, glucose, and KGM media
were subtracted from the sample values. Statistically significant differences for butyrate concentration were determined with the Mann-Whitney test using
SCFA data.
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(7), the end products of this pathway enter glycolysis either directly (glucose) or after
being converted to mannose-6-phosphate and fructose-6-phosphate by the phospho-
mannose mutase FpPmm and the isomerase FpGH1, respectively. Released galactose
and mannose are converted to galactose-1-phosphate (via the Leloir pathway) and man-
nose-6-phosphate (by a hexokinase) before entering glycolysis (7). The pyruvate gener-
ated from glycolysis is then partly converted to butyrate (33). A comparative genomic
analysis revealed that the FpMULs are widespread and highly conserved among human
gut-associated F. prausnitzii (Fig. 1a). The presence of genes associated with conjugation
and phage-related events in the flanking regions suggests that the FpMULL was acquired
through horizontal gene transfer from other gut bacteria, as previously observed for
PULs identified in commensal Bacteroides genomes (34).
Members of the dominant Bacteroides genus, such as B. ovatus, as well as Firmicutes
species, like Roseburia, that possess GH26 endomannanases have been described as
the keystone bacteria for b-mannan degradation in the gut (7, 21, 31). In contrast,
F. prausnitzii may only access oligosaccharides, released by these primary degraders,
which can be imported without the need for extracellular enzymatic cleavage. In this
context, we demonstrate that b-MOS are indeed released into the culture medium by
B. ovatus during cogrowth on KGM and that F. prausnitzii is capable of efficiently com-
peting for and utilizing these oligosaccharides (Fig. 5g). Similarly, we observed evi-
dence of cooperative growth between R. intestinalis and F. prausnitzii when cocultured
in KGM (Fig. 5o). We recently demonstrated the competitiveness of R. intestinalis on
b-mannan when in coculture with B. ovatus during growth on AcGGM (7), and high-
lighted a pivotal role of a transport protein (RiMnBP) within the uptake system, which
exhibited strong binding to short b-MOS (degree of polymerization [DP], 3 to 6) with
different side chain decoration patterns (7). Similar observations were recently
reported for the Bifidobacterium genus, with B. animalis subsp. lactis ATCC 27673 out-
competing B. ovatus during growth on galactomannan (35). Notably, the two B. ani-
malis binding proteins, BlMnBP2 and BlMnBP1, mediated high-affinity capture of
b-MOS with preference to oligosaccharides with a DP of 3 to 4 and Kd values in the 70
to 80 nM range (35). In contrast, the SusD-like b-MOS-binding proteins from B. ovatus
displayed binding to M6 (Kd value of 1.86 0.2mM) (31) with about 10-fold lower affinity
than that of FpMOBP, 53-fold lower affinity than that of RiMnBP, and about 900-fold
lower affinity than that of BlMnBP2 and BlMnBP1. The results shown in Fig. 5g and o
show that the growth of F. prausnitzii was much more pronounced when in cocultures
with B. ovatus (Fig. 5g) (with an average 16S rRNA gene copies per ml of culture of
5.91E18 F. prausnitzii and 1.34E109 B. ovatus, corresponding to a ratio of 2.3:1 B. ova-
tus-F. prausnitzii) than in F. prausnitzii-R. intestinalis cocultures (Fig. 5o) (with an average
16S rRNA gene copies per ml of culture of 1.24E18 F. prausnitzii and 6.94E18 R. intesti-
nalis, corresponding to a ratio of 5.6:1 R. intestinalis-F. prausnitzii). This is consistent
with the fact that F. prausnitzii FpMOBP is more efficient in capturing oligosaccharides
from the “weaker” binding of SusD-like b-MOS-binding protein of B. ovatus than from
the R. intestinalis RiMnBP. Thus, the differential transporter affinity to b-MOS provides
a possible rationale for the trophic interactions established by F. prausnitzii with
Bacteroides, enabling efficient capture of communally available nutrients within syn-
thetic consortia, and potentially in natural gut communities. On the other hand, the
binding affinity of MnBPs plausibly gives a reason as to why cross-feeding on KGM was
present to a lower extent in the R. intestinalis and F. prausnitzii coculture and why the
affinity of RiMnBP to M6 (Kd value of 33.756 0.95mM) was five times stronger than that
of FpMOBP. This difference is likely to be crucial for selfish resource capture by the key-
stone b-mannan primary degrader R. intestinalis (7) with minimal loss of valuable
nutrients in a competitive environment.
To understand the capacity of human populations to derive nutrition from b-MOS,
we surveyed 2,441 publicly available human metagenomes and revealed that MULs
closely related to those of F. prausnitzii are widely distributed throughout human pop-
ulations (Fig. 1b). Indeed, we did not observe correlation with any particular
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population or nation, consistent with the fact that dietary b-MOS/b-mannan are a
ubiquitous component of the human diet. The FpMULs were more common than pop-
ulation restricted traits like red algal porphyran degradation, known to be confined to
a small cohort of Japanese subjects and absent in the microbiome of Western individu-
als (34), but they were less common than Bacteroides-associated PULs for degradation
of plant cell wall xyloglucan (92% of samples) (36), mixed-linkage b-glucans (92.5% of
samples) (37), b-(1, 3)-glucans (59% of samples) (38), and yeast a-mannans (62% of
samples) (39). Moving beyond the human microbiota, we detected two analogous
FpMULs in a F. prausnitzii strain found in the porcine gut microbiota (40). Proteomic
analysis identified FpMUL-encoded proteins being more abundant in pigs fed a diet
supplemented with 4% AcGGM, thus providing evidence that these analogous MULs
are employed by F. prausnitzii inhabiting environments beyond the human gut (40).
In conclusion, biochemical and microbiological data presented in this study illus-
trate that F. prausnitzii possesses an extensive enzymatic apparatus that targets b-MOS
released by neighboring colonic bacteria. ITC data provide evidence that the external
recognition machinery is tailored for the capture of b-MOS with stronger affinity than
Bacteroides. This is in line with the fact that, when in coculture, F. prausnitzii showed
cross-feeding behaviors with B. ovatus, whose own b-MOS uptake requires a SusD-like
protein that binds oligosaccharides with about 10-fold-lower affinity than that of
FpMOBP. Furthermore, this study in conjunction with a previous report (7) points to a
competitive mechanism of b-MOS/b-mannan utilization in the gut microbiota where
keystone Lachnospiraceae members like R. intestinalis have developed a sophisticated
“selfish” uptake and degrading system to minimize sharing resources with Bacteroides
and Ruminococcaceae species such as F. prausnitzii.
Overall, our study contributes toward the understanding of cross-feeding mecha-
nisms deployed by a beneficial commensal microorganism to interact with dietary
b-mannan. Significantly, these findings could help to design prebiotic/symbiotic for-
mulations that are optimized for selective manipulation of gut microbiome functions
in ways that promote human health and beyond.
MATERIALS ANDMETHODS
Substrates. All glycan stocks were prepared at 10mg/ml in double-distilled water (ddH2O) and steri-
lized by filtration using a 0.22-mm membrane filter (Sarstedt AG & Co., Germany).
(i) Polysaccharides. Konjac glucomannan and carob galactomannan were purchased from Megazyme
International (Wicklow, Ireland).
(ii) Oligo- and monosaccharides. Mannose (M1) and glucose (G1) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Xylopentaose (X5), cellobiose (G2), cellotetraose (G4), mannobiose (M2), manno-
triose (M3), mannotetraose (M4), mannopentaose (M5), mannohexaose (M6), 6
1-a-D-galactosyl-mannotriose
(GalM3), and 6
3,64-a-D-galactosyl-mannopentaose (Gal2M5) were purchased from Megazyme. Konjac gluco-
mannan digest and carob galactomannan digest were produced in-house using RiGH26 (7) in 10mM so-
dium phosphate (pH 5.8). Reaction mixtures were incubated for 16 h at 37°C following removal of RiGH26
using a Vivaspin 20 filtration unit (10,000-molecular-weight-cutoff [MWCO] polyethersulfone [PES];
Sartorius) and carbohydrate lyophilization on an ALPHA 2-4 LD Plus freeze dryer (Christ, Germany).
Acetylated galactoglucomannan (AcGGM) was produced in-house as described by La Rosa et al. (24).
Bacterial strains and culture conditions. Faecalibacterium prausnitzii SL3/3, Roseburia intestinalis
L1-82, and Bacteroides ovatus V975 were routinely cultured with CO2 at 37°C in M2 medium containing
30% clarified rumen fluid supplemented with 0.2% (wt/vol) glucose, soluble potato starch, and cello-
biose (GSC) (41). These bacterial isolates were from stocks held by the authors (S. H. Duncan, Rowett
Institute of Nutrition and Health, Aberdeen, United Kingdom), and all are of human fecal origin (23, 42,
43). Growth measurements on individual substrates were performed in M2GSC medium containing a sin-
gle carbohydrate at 0.2% (wt/vol) final concentration using 96-well plates in a Don Whitley MACS-VA500
workstation (80% N2, 10% H2, and 10% CO2). Growth was assessed by measuring the absorbance at
650 nm (optical density at 650 nm [OD650]) at 2-h intervals for up to 24 h using an Epoch 2 microplate
reader (BioTek, VT, USA). The competition assays of F. prausnitzii and either B. ovatus or R. intestinalis
were conducted by growing the strains as described above in the presence of 0.2% (wt/vol) konjac glu-
comannan. The strains inoculated into M2 medium with no added carbohydrate source and M2 medium
with 0.2% (wt/vol) glucose were included as negative and positive controls, respectively. Five-microliter
samples of overnight bacterial cultures from both strains were used to inoculate the wells (final volume
of 200 ml). The cocultures were incubated at 37°C anaerobically, and growth was followed by measuring
the OD650 for 24 to 48 h. Samples were collected at the end of the experiment, cells were pelleted for
subsequent DNA extraction, and the supernatant (500 ml) was used for SCFA analysis. All growth experi-
ments were performed in triplicate.
b-MOS Depolymerization by Faecalibacterium prausnitzii ®













































DNA extraction and quantitative PCR. After the growth experiments involving single cultures and
cocultures were completed, cell pellets were obtained from triplicate wells for each condition tested
(600 ml) and the bacterial inoculum (600 ml). The cell pellets were resuspended in 978 ml sodium phos-
phate buffer and 122 ml MT buffer and stored at –70°C until DNA extraction, which was performed using
the FastDNA SPIN kit for Soil (MP Biomedicals, Irvine, CA, USA) following the manufacturer’s instructions.
The extracted DNA from the mono- and coculture experiments was analyzed using quantitative PCR as
described by Chung et al. (44) with some modifications. Herring sperm (HS) DNA (5 ng/ml) (Promega,
Madison, WI, USA) was used to dilute the samples and 16S PCR products of reference strains to obtain a
10-fold dilution series for standard curves. A master mix containing iTaq Universal SYBR green Supermix
(Bio-Rad, Hemel Hempstead, UK), 10mM primer pairs (500 nM final concentration), and molecular biol-
ogy grade water was prepared. The master mix (8 ml) together with 2 ml of either a diluted sample
(1 ng/ml) or standard, giving a total volume of 10 ml, was distributed into the wells of 384-well plates.
The plates were then sealed with optical seals (Bio-Rad). Samples were amplified with universal primers
(UniF and UniR) against total bacteria and specific primers targeting Roseburia spp. (44), Bacteroides spp.
(44), and F. prausnitzii. Specific primers against F. prausnitzii (100.85%6 1.53% efficiency) were designed
as part of this study (see Table S2 in the supplemental material). The Bio-Rad CFX384 real-time system
was used for the amplification of samples and standards using the protocol described previously with
annealing temperatures appropriate for each primer set (Table S2). The reactions were performed in
duplicate, and the number of 16S rRNA gene copies per milliliter of culture for each bacterial strain in
the mixes tested were determined using information from the standard curves. Negative controls con-
taining only herring sperm (HS) DNA were used to determine the detection limit.
Bioinformatics, cloning, expression, and purification of recombinant proteins. F. prausnitzii SL3/
3’s FpMULL and FpMULS were identified by tBLASTn-based homology searches using the amino acid
sequences of the proteins from the previously characterized R. intestinalis b-mannan degradation sys-
tem as the query (7). The genes encoding mature forms of the proteins described in this study were
amplified from the F. prausnitzii SL3/3 genomic DNA (BioProject accession number PRJNA39151) by PCR
using appropriate primers (Table S1). All primers were designed to amplify constructs to exclude pre-
dicted signal peptides (predicted by the SignalP v4.1 server [45]). PCR products were generated using
the Q5 High-Fidelity DNA polymerase (New England BioLabs, United Kingdom) with 50 ng genomic DNA
as the template. The PCR products were cloned into pNIC-CH (Addgene plasmid 26117) by ligation-inde-
pendent cloning (46). All constructs were designed to harbor a C-terminal His6 tag fusion in the trans-
lated recombinant peptide, although for FpGH36, His tag translation was prevented by the introduction
of one stop codon at the end of the open reading frame. Successful generation of constructs was veri-
fied by sequencing (Eurofins, UK). Plasmids harboring the gene of interest were transformed into chemi-
cally competent Escherichia coli BL21 STAR cells (Invitrogen), and an overnight preculture was inoculated
to 1% in 500ml tryptone yeast extract (TYG) containing 50mg/ml kanamycin, followed by incubation of
the fresh culture for 16 h at 25°C. Protein overexpression was induced by adding isopropyl b-D-thioga-
lactopyranoside (IPTG) to a final concentration of 200mM. Recombinant protein production continued
overnight at 25°C, after which the cells were collected by centrifugation. FpCE17, FpCE2, FpGH113, and
FpMOBP were purified by immobilized metal ion affinity chromatography (IMAC). To this aim, the har-
vested cell pellet was resuspended in binding buffer (20mM sodium phosphate [pH 7.4], 500mM so-
dium chloride, 5mM imidazole) and lysed using a Vibracell ultrasonic homogenizer (Sonics and
Materials, USA). The cell debris was pelleted by centrifugation, and the supernatant was loaded onto a
5-ml HisTrap IMAC HP nickel Sepharose column (GE Healthcare), using an ÄKTA Pure chromatography
system (GE Healthcare). The target His-tagged protein was eluted using a linear gradient of 0 to 100%
elution buffer (20mM sodium phosphate [pH 7.4], 500mM sodium chloride, 500mM imidazole) over 16
column volumes. FpGH36 was purified by hydrophobic interaction chromatography (HIC). FpGH36-con-
taining cell pellet was resuspended in a buffer with 1.5M ammonium sulfate and lysed as described
above. The cell-free supernatant was loaded onto a 5-ml HiTrap Phenyl FF (GE Healthcare), and protein
was eluted by using a linear reverse gradient to 100mM NaCl over 90min at a flow rate of 2.5ml/min.
After IMAC or HIC purification, eluted protein fractions were pooled, concentrated using a Vivaspin 20
centrifugal concentrator (10-kDa molecular weight cutoff), and applied to a HiLoad 16/600 Superdex
75 pg gel filtration column (GE Healthcare). Pure protein samples were dialyzed against 10mM Tris-HCl
(pH 7.0) and concentrated as described above. Protein purity was determined by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. Protein concentrations were determined
using the Bradford assay (Bio-Rad, Germany).
Activity assays. Unless otherwise stated, enzyme reaction mixtures contained 10mM sodium phos-
phate (pH 5.8) and 0.1mg/ml substrate. Reaction mixtures were preheated (37°C for 10min) in a
Thermomixer C incubator with a heated lid (Eppendorf), before addition of the enzyme to 1mM (in a
final reaction mixture volume of 100ml) for further incubation (up to 16 h) at 37°C and 700 rpm. All
experiments were performed in triplicate.
MALDI-ToF MS analysis of oligosaccharides. Mannooligosaccharide products were analyzed by
matrix-assisted laser desorption ionization2time of flight mass spectrometry (MALDI-ToF MS) on a
Ultraflex MALDI-ToF/ToF MS instrument (Bruker Daltonics, Germany) equipped with a 337-nm-wave-
length nitrogen laser and operated by the MALDI FlexControl software (Bruker Daltonics). A matrix of
2,5-dihydroxybenzoic acid (DHB) (0.9% 2,5-dihydroxybenzoic acid–30% acetonitrile [vol/vol]) was used.
All measurements were performed in positive ion, reflector mode with 1,000 shots taken per spectrum.
Carbohydrate analysis using high-performance anion-exchange chromatography. Oligo- and
monosaccharides were analyzed by high-performance anion-exchange chromatography with pulsed
amperometric detection (HPAEC-PAD) on a Dionex ICS-3000 system operated by Chromeleon software
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version 7 (Dionex). Sugars were loaded onto a CarboPac PA1 2 250-mm analytical column (Dionex,
Thermo Scientific) coupled to a CarboPac PA1 2 50-mm guard column kept at 30°C. Depending on the
analytes, the following gradients were used. The system was run at a flow rate of 0.25ml/min. For
manno-oligosaccharides, the elution conditions were as follows: for 0 to 9min, 0.1 M NaOH; for 9 to
35min, 0.1 M NaOH with a 0.1 to 0.3 M sodium acetate (NaOAc) gradient; for 35 to 40min, 0.1 M NaOH
with 0.3 M NaOAc, and for 40 to 50min 0.1 M NaOH. Commercial mannose and manno-oligosaccharides
(DP, 2 to 6) were used as external standards.
Acetate release measurements using high-performance liquid chromatography. Acetate content
in the samples was analyzed on an RSLC Ultimate 3000 (Dionex, USA) high-performance liquid chromato-
graph (HPLC) using a REZEX ROA-Organic Acid H1 300 7.8-mm ion exclusion column (Phenomenex,
USA). The injection volume was 5ml, and separation was conducted at 65°C, with isocratic elution using
0.6ml/min of 5mM H2SO4 as the mobile phase. The UV detector was set at 210nm. Data collection and
analysis were carried out with the Chromeleon 7.0 software (Dionex).
SCFA analysis. SCFA concentrations were measured using a gas chromatograph analyzer equipped
with a flame ionization detector (GC-FID) as described previously (47). Following derivatization of the
samples using N-tertbutyldimethylsilyl-N-methyltrifluoroacetamide, the samples were analyzed on a
Hewlett-Packard 6890 gas chromatograph equipped with a silica capillary column using helium as the
carrier gas. Quantification of SCFA in the chromatograms was determined based on the retention times
of the respective SCFA standards (Sigma-Aldrich, United Kingdom) at concentrations ranging between
5 and 30mM.
Isothermal titration calorimetry. Binding of mannohexaose and cellohexaose to FpMOBP was
measured at 25°C in 50mM sodium phosphate (pH 6.5) using either a MicroCal ITC200 microcalorimeter
or a MicroCal VP-ITC system. To assess the binding to mannohexaose using a MicroCal ITC200 microca-
lorimeter, FpMOBP in the sample cell (2.5mM) was titrated by a first injection of 0.5ml followed by
19 2-ml injections of carbohydrate ligand (2.5mM) with 120 s between injections. To evaluate the bind-
ing to cellohexaose using a MicroCal VP-ITC system, FpMOBP in the sample cell (22.5mM) was titrated by
a first injection of 2ml followed by 29 6-ml injections of carbohydrate ligand (2.5mM) with 180 s
between injections. Thermodynamic binding parameters were determined using either the MicroCal
Origin software (version 7.0) or the VPviewer2000 software (version 2.6).
FpCE2 and FpCE17 optimal pH. The pH optima for FpCE17 and FpCE2 were assessed by incubation
of the enzymes with 0.5mM 4-nitrophenyl (pNP) acetate (Sigma-Aldrich, Germany) at 25°C using 50mM
sodium phosphate buffer at pHs ranging from 5.0 to 8.0. Due to the difference in deacetylation rate of
pNP acetate by the two enzymes, 1 nM FpCE2 and 0.1 mM FpCE17 were used in these experiments.
Standard plots of 4-nitrophenol (p-nitrophenol; Sigma-Aldrich) were prepared at each pH. The experi-
ments were conducted in triplicate in a volume of 100ml of sample mixture in 96-well microtiter plates.
The reaction was followed by measuring the absorbance at 405 nm at 1-min intervals for 10 min using a
Microplate reader (BioTek, USA).
Protein thermal shift assay. The thermal stability of FpCE17 and FpCE2 was examined using the
Protein Thermal Shift kit (ThermoFisher, USA) by measuring fluorescence in a real-time PCR system
(Applied Biosystems, USA). A final concentration of 0.1mg/ml of FpCE17 and FpCE2 was used in 50mM
sodium phosphate buffers at pH 5.0 to 8.0 and mixed with ROX dye according to the kit protocol. The
melting temperature was executed in four replicates with temperatures from 25 to 99°C in 1% incre-
ments. The data were processed using the StepOne software (Applied Biosystems, USA).
Transesterification reactions. Transesterification of oligosaccharides was conducted using vinyl ac-
etate (Thermo Scientific, USA) as acetate donors. Enzymes (1mg/ml final concentration) were mixed with
1mg/ml oligosaccharides, and a volume of vinyl acetate corresponding to 50% of the sample volume
was added. The samples were incubated in a thermomixer (Eppendorf, Norway), shaking at 600 rpm, at
ambient temperature overnight, then kept at –20°C until frozen. The vinyl acetate, which remained in
liquid phase on top of the frozen aqueous phase, was discarded; enzyme deactivation and carbohydrate
precipitation were achieved by adjusting the aqueous phase to 80% (vol/vol) ethanol with ice-cold 96%
ethanol. Enzymes were removed through filtration using a 1-ml Amicon Ultracel 3-kDa ultrafiltration de-
vice (Merck KGaA, Germany). The samples were then dried using an Eppendorf Concentrator plus
(Eppendorf, Norway) at 30°C, and the material was dissolved in 100ml dH2O.
Comparative genomics analysis. Searches for the presence of MULL and MULS in other publicly
available F. prausnitzii genomes were conducted using a similar strategy as described previously (7).
Briefly, the identification of similar MULs in strains other than F. prausnitzii SL3/3 was done using
BLASTN and the Gene Ortholog Neighborhood viewer on the Integrated Microbial Genomes website
(https://img.jgi.doe.gov) using the sequences of the genes coding for FpMOBP (FPR_17280), FpGH113
(FPR_17310), and FpGH3 (FPR_09740) as the search homolog and the default threshold E value of 1e25.
If this generated a hit, we repeated the process with the adjacent gene to verify that the locus was found
in the identified strain. Then, the amino acid identities between each F. prausnitzii SL3/3 MULL-MULS
RefSeq annotated protein and the hits identified in other F. prausnitzii strains were determined by
BLASTP-based analyses. Finally, we compared the genomic regions surrounding each orthologous MUL
for gene conservation and amino acid identities.
Analysis of human gut metagenomic data sets for the presence of MULs. Available cohorts of
human gut metagenomic sequence data (National Center for Biotechnology Information projects:
PRJNA422434 (48), PRJEB10878 (49), PRJEB12123 (50), PRJEB12124 (51), PRJEB15371 (52), PRJEB6997
(53), PRJDB3601 (54), PRJNA48479 (20), PRJEB4336 (55), PRJEB2054 (56), PRJNA392180 (57), and
PRJNA527208 (58) were searched for the presence of MUL nucleotide sequences from F. prauznitzii
MULL (17.5 kb) and F. prauznitzii MULS (5.5 kb) using the following workflow. Each MUL nucleotide
b-MOS Depolymerization by Faecalibacterium prausnitzii ®













































sequence was used separately as a template, and then Magic-BLAST (59) v1.5.0 was used to recruit raw
Illumina reads from the available metagenomic data sets with an identity cutoff of 97%. Next, the align-
ment files were used to generate a coverage map using bedtools (60) v2.29.0 to calculate the percent-
age coverage of each sample against each individual reference. We considered a metagenomic data
sample to be positive for a particular MUL if it had at least 70% of the corresponding MUL nucleotide
sequence covered.
Data availability. All data supporting the findings of this study are available within the article and
supplemental material.
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